ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01570127
Recruitment Status : Unknown
Verified April 2012 by Dongwoo Nam, Kyunghee University Medical Center.
Recruitment status was:  Recruiting
First Posted : April 4, 2012
Last Update Posted : April 6, 2012
Sponsor:
Collaborators:
Ministry of Health & Welfare, Korea
Gachon University Gil Medical Center
Information provided by (Responsible Party):
Dongwoo Nam, Kyunghee University Medical Center

March 26, 2012
April 4, 2012
April 6, 2012
October 2010
August 2012   (Final data collection date for primary outcome measure)
The change of 100mm pain Visual Analog Scale(VAS) after 6 weeks of treatment. [ Time Frame: at baseline and after 6 weeks of treatment. ]
Visual analog scale (VAS) is a tool used to measure pain. The patient is asked to indicate their perceived pain intensity along a 100 mm horizontal line, where '0' represents 'no pain' and '100', 'unbearable pain'. The change of pain will be reported by comparing the mean VAS before treatment and after the 6 week trearment period.
Same as current
Complete list of historical versions of study NCT01570127 on ClinicalTrials.gov Archive Site
  • Roland - Morris Disability Questionnaire [ Time Frame: at 2nd(baseline), 8th(after 4 weeks of treatment), 13th(end of study) and 14th(follow up) visit ]
    Roland - Morris Disability Questionnaire (RMDQ) is scored by adding up the number of items checked by the patients, among the 24 items concerning various disablilities caused by low back pain. The score can therefore vary from 0 to 24. Higher the scores represent worse disabilities.
  • SF-36 [ Time Frame: at 2nd(baseline), 8th(after 4 weeks of treatment), 13th(end of study) and 14th(follow up) visit ]
    The 36 questions yields an 8-scale health profile. It is useful in monitoring the change in health related quality of life.
  • Adverse Events [ Time Frame: at 2nd(baseline), 3rd, 4th, 5th, 6th, 7th, 8th, 9th, 10th, 11th, 12th and 13th(end of study) ]
    Any unpredicted symptoms were checked at each follow up visit and if any, the symptom, time of occurrence, and length of duration were recorded and reported.
Same as current
Not Provided
Not Provided
 
Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Low Back Pain
Clinical Trial to Evaluate and Compare the Efficacy and Safety of Individualized and Standardized Acupuncture for Low Back Pain Patients: Randomized, Double-blind, Controlled Study
The purpose of this study is to determine whether acupuncture treatment(Individualized & Standardized Acupuncture) is more effective than control (sham acupuncture or no treatment) and also whether individualized acupuncture is more effective than standardized acupuncture.

To determine whether individualized acupuncture is more effective than standardized acupuncture, 276 Low Back Pain patients will be recruited and randomly assigned to 4 separate groups.

Experimental groups(Individualized Acupuncture Group and Standardized Acupuncture Group) and Control groups (Sham acupuncture and waiting list)

The change of pain and physical functions will be compared among the four groups.

So the efficacy of acupuncture, and the best acupuncture treatment model will be determined. Also in addition, safety and abnormal reactions of acupuncture treatments will be evaluated.

Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Low Back Pain
  • Procedure: Individualized Acupuncture
    The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions)
  • Procedure: Standardized Acupuncture
    The treatment was applied twice a week for 20 minutes for 6 weeks(12sessions) 8 Acupuncture points, GV4, GV3, BL24(bilateral), BL25(bilateral) and GB30(bilateral) were used for all the patients assigned to this group. Sterile Stainless Steel(25mm x 40mm) disposable acupuncture needles manufactured by Dong-Bang Acupuncture Co.(Korea) were used.
  • Procedure: Sham Acupuncture
    The treatment was applied twice a week for 6 weeks(12sessions). The sham acupuncture was applied on the 8 same acupuncture points as in the standardized acupuncture group, GV4, GV3, BL24(bilateral), BL25(bilateral) and GB30(bilateral). Each session was 20 minutes long.
    Other Name: Park Sham Device
  • Other: Waiting
    No interventions were applied to the patients in this group.
    Other Name: No interventions
  • Experimental: Individualized Acupuncture
    The patients in this group received individualized acupuncture prescribed by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on the pattern diagnosis, which is an unique diagnosis system of Oriental Medicine.
    Intervention: Procedure: Individualized Acupuncture
  • Experimental: Standardized Acupuncture
    The patients in this group received standardized acupuncture treatment using the same acupuncture points, applied by a certified Korean Medicine Doctor with more than 6 years of oriental medicine college education and 2 years of clinical experience. The acupuncture formulas were composed based on literature review of RCTs.
    Intervention: Procedure: Standardized Acupuncture
  • Sham Comparator: Sham acupuncture
    Non-penetrating acupuncture device, Park-sham acupuncture, was applied to the patients. The appearance of the acupuncture is same but the needles do not penetrate the skin.
    Intervention: Procedure: Sham Acupuncture
  • No Intervention: Waiting
    No interventions were applied to the patients in this group. Only assessments were made at each visit.
    Intervention: Other: Waiting
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
276
Same as current
December 2012
August 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male and female patients suffering Low Back Pain.
  • Patients classified as Class 1(pain in the lumbar area, without radiation below the gluteal fold and in the absence of neurologic signs) or Class 2(Low back pain with radiation of pain not beyond the knee, no neurological signs) according to the Quebec Task Force System
  • Suffering pain which is more than 40mm on VAS(Visual Analog Scale)
  • Voluntary participants who have completed the consent.

Exclusion Criteria:

  • Low back trauma history within 6 months.
  • Low back surgery history within 6 months.
  • Low back pain caused by malignancy, inflammatory disease, fibromyalgia, vertebral fracture, infection, juvenile scoliosis or congenital malformation.
  • Pain in other parts of the body more severe than low back pain.
  • Mental problems that can influence the pain or results of questionnaire.
  • Diseases that can interfere absorption, metabolism and excretion of medicine.
  • History of alcohol or drug abuse within 12 months of the study.
  • Pregnant, breastfeeding or childbearing aged women who are not using any birth control methods.
Sexes Eligible for Study: All
Child, Adult, Older Adult
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01570127
KOMCIRB-02-20101130-02
Yes
Not Provided
Not Provided
Dongwoo Nam, Kyunghee University Medical Center
Dongwoo Nam
  • Ministry of Health & Welfare, Korea
  • Gachon University Gil Medical Center
Study Chair: Jae-Dong Lee, Ph.D Kyunghee University Medical Center
Kyunghee University Medical Center
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP